“Electrocardiographic and biochemical adverse effects of meglumine antimoniate (MA) during treatment of Syrian cutaneous leishmaniasis patients” (2016) Journal of Pakistan Association of Dermatologists, 23(4), pp. 412–417. doi:10.66344/jpad.v23i4.289.